BLOG

The recently published 2023 EFSA report on veterinary drug residues confirms continued high compliance with EU limits, with non-compliant samples remaining at an impressively low 0.11%.

Antimicrobial resistance (AMR) in animals remains a pressing concern, with recent findings from EFSA revealing continued resistance in bacteria like Salmonella and Campylobacter.